SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is experiencing explosive momentum, driven by a massive short squeeze following a new strategic deal, with many comparing its parabolic ascent to legendary past runners. The community is buzzing with excitement and disbelief over the rapid gains, focusing on its low float and high short interest as key factors fueling the dramatic price action.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community emphasizes a 'Bongterm' vision, prioritizing cultural sovereignty and consistent, patient growth on the Solana blockchain. Discussions highlight its identity as a 'plant-paced project' focused on education and community values, often proclaiming it as 'like Bitcoin but way higher' due to its enduring connection to evolving cannabis culture and broader societal shifts.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following the completion of its Astria Therapeutics acquisition, which significantly expands its hereditary angioedema (HAE) pipeline with the late-stage drug navenibart. The community is actively discussing the strategic implications, including favorable new financing terms and a recent ORLADEYO price increase, while debating preliminary guidance that some view as conservative sandbagging by new leadership. Amidst strong revenue growth and expectations for profitability, many express frustration over the stock's perceived undervaluation and ongoing market dynamics.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci Corp

Cel-Sci (CVM) is trending as the community hotly debates the imminent potential approval of its Multikine treatment by the Saudi Food and Drug Authority (SFDA), a decision keenly watched by investors. Enthusiasts cite a strategic partnership and encouraging trial subgroup data as positive indicators, while critics express concern over past development timelines, ongoing equity dilution, and questions about the product's broader regulatory path, particularly in the US.

AXS is the governance token for the Axie Infinity game. Token holders will be able to shape and vote for the direction of the game universe. This is unlike traditional games where all decisions are made by the game developers. AXS holders will be able to stake their tokens to earn more AXS and even vote for governance proposals.

Axie Infinity

Axie Infinity (AXS) is trending amid renewed interest in gaming tokens, with community discussions buzzing around recent developments and potential catalysts. Speculation about integrations like Apple Vision Pro and the launch of its AI agent, JAIHOZ, are driving conversations. Many anticipate Axie Infinity could be entering a significant accumulation phase, drawing comparisons to its historical market performance as the GameFi sector gains momentum.

Trump For President

TRUMP CRYPTO is actively trending amid intense community discussion, largely driven by political developments surrounding Venezuela and broader speculation about global influence. While supporters link the coin's potential for significant gains to the former president's ongoing political actions, many others express strong skepticism, highlighting the asset's volatility and lack of intrinsic value.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a hot topic among traders following a new manufacturing partnership aimed at bolstering production and margins, coupled with a significant private placement. The community is actively discussing the potential for a short squeeze, citing a low float and high cost to borrow, while also debating the impact of future share dilution. Anticipation for pending FDA approval for its non-invasive drug testing technology is a key factor in long-term sentiment.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is a focal point with an anticipated earnings report approaching, while community chatter is heavily influenced by executive share sales and evolving regulatory discussions around social media use by minors. Bullish sentiment highlights its extensive youth user base and potential AI innovations, contrasting with bearish concerns over persistent profitability challenges and perceived weak management. The stock frequently sees significant short-term price swings as these opposing views clash, with many looking for a catalyst to break its established trading range.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is actively trending as new independent test results confirm its AI-1 battery's high energy density and collaborations for smart eyewear emerge from industry events. Community discussion is sharply divided between optimism for future mass production and adoption in devices like smart glasses and smartphones, and skepticism driven by previous timeline adjustments and a recent executive transition.

NeoVolta, Inc. engages in the designing, manufacturing, and developing of residential energy storage systems (ESS). Its products include: NV14, NV24, NVPlus, NV7600, and NV16. The company was founded by Brent Willson on March 5, 2018 and is headquartered in Poway, CA.

NeoVolta Inc

NeoVolta is trending following its pivotal joint venture to establish a U.S. battery manufacturing platform, positioning it as a key player in the expanding energy storage market. This development, combined with the company's low float and notable short interest, is igniting widespread community discussion around a potential short squeeze. Investors are closely watching for sustained momentum as the company expands its presence in the burgeoning clean energy sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QRG Capital Management Inc. Decreases Holdings in Fidelity National Financial, Inc. $FNF

QRG Capital Management Inc. lowered its position in Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 74.1% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Fidelity National Financial, Inc. $FNF Shares Sold by Schwartz Investment Counsel Inc.

Schwartz Investment Counsel Inc. reduced its stake in shares of Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 7.5% in the 3rd quarter, according to its most recent disclosure with the...

Fidelity National Financial (NYSE:FNF) Upgraded at Wall Street Zen

Wall Street Zen raised shares of Fidelity National Financial from a "hold" rating to a "buy" rating in a research note on Sunday...

Sumitomo Mitsui Trust Group Inc. Has $39.03 Million Position in Fidelity National Financial, Inc. $FNF

Sumitomo Mitsui Trust Group Inc. cut its holdings in Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 5.3% in the 3rd quarter, according to the company in its most recent filing with the...

New York State Teachers Retirement System Has $6.70 Million Holdings in Fidelity National Financial, Inc. $FNF

New York State Teachers Retirement System lowered its position in Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 18.4% during the third quarter, according to its most recent filing...

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Boosts Stock Position in Fidelity National Financial, Inc. $FNF

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its stake in shares of Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 745.2% during the third quarter, according to the...

Fidelity National Financial, Inc. $FNF Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC trimmed its holdings in shares of Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 51.2% during the third quarter, according to its most recent Form 13F filing...

Fidelity National Financial, Inc. $FNF Holdings Decreased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. cut its position in shares of Fidelity National Financial, Inc. (NYSE:FNF - Free Report) by 94.9% during the 3rd quarter, according to its most recent...

Barclays Issues Pessimistic Forecast for Fidelity National Financial (NYSE:FNF) Stock Price

Barclays decreased their target price on Fidelity National Financial from $64.00 to $63.00 and set an "equal weight" rating for the company in a research report on Tuesday...

Pacer Advisors Inc. Takes Position in Fidelity National Financial, Inc. $FNF

Pacer Advisors Inc. purchased a new stake in shares of Fidelity National Financial, Inc. (NYSE:FNF - Free Report) during the third quarter, according to its most recent filing with the Securities...

Fidelity National Financial, Inc. engages in the provision of title insurance and transaction services to the real estate and mortgage industries. Its services include title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances, and home warranty products and technology and transaction services to the real estate and mortgage industries. The company operates through the following segments: Title, F&G, and Corporate and Other. The Title segment consists of the operations of title insurance underwriters and related businesses. The F&G segment consists of operations of annuities and life insurance related businesses. The Corporate and Other segment is involved in real estate brokerage businesses. Fidelity National Financial was founded by William P. Foley II in 1984 and is headquartered in Jacksonville, FL.

Fidelity National Financial Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

FNF
Fidelity National Financial Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FNF News

FNFFidelity National Financial Inc